These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20629621)

  • 1. Homocysteine, intracellular signaling and thrombotic disorders.
    Dionisio N; Jardín I; Salido GM; Rosado JA
    Curr Med Chem; 2010; 17(27):3109-19. PubMed ID: 20629621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
    Papatheodorou L; Weiss N
    Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelial dysfunction in patients with primary hypertension and hyperhomocysteinemia].
    Baszczuk A; Kopczyński Z; Thielemann A
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():91-100. PubMed ID: 24491900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
    Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
    Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine, coagulation, platelet function, and thrombosis.
    Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine models of hyperhomocysteinemia and their vascular phenotypes.
    Dayal S; Lentz SR
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1596-605. PubMed ID: 18556571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of thrombosis in hyperhomocysteinemia.
    Lentz SR
    Curr Opin Hematol; 1998 Sep; 5(5):343-9. PubMed ID: 9776214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats.
    Durand P; Lussier-Cacan S; Blache D
    FASEB J; 1997 Nov; 11(13):1157-68. PubMed ID: 9367351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia and atherothrombotic disease.
    de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
    Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote ischemic conditioning as a cytoprotective strategy in vasculopathies during hyperhomocysteinemia: An emerging research perspective.
    Majumder A; Singh M; George AK; Homme RP; Laha A; Tyagi SC
    J Cell Biochem; 2019 Jan; 120(1):77-92. PubMed ID: 30272816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies.
    Sharma P; Senthilkumar RD; Brahmachari V; Sundaramoorthy E; Mahajan A; Sharma A; Sengupta S
    Lipids Health Dis; 2006 Jan; 5():1. PubMed ID: 16430779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin α(IIb)β₃ exists in an activated state in subjects with elevated plasma homocysteine levels.
    McGarrigle SA; O'Neill S; Walsh GM; Moran N; Graham IM; Cooney MT; Monavari A; Mayne P; Collins P
    Platelets; 2011; 22(1):65-73. PubMed ID: 21133649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
    Fridman O
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview.
    Herrmann W
    Clin Chem Lab Med; 2001 Aug; 39(8):666-74. PubMed ID: 11592431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.